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ABSTRACT T-cell activation is essential for initiation and control of immune system function. T cells are activated by
interaction of cell-surface antigen receptors with major histocompatibility complex (MHC) proteins on the surface of other
cells. Studies using soluble oligomers of MHC–peptide complexes and other types of receptor cross-linking agents have
supported an activation mechanism that involves T cell receptor clustering. Receptor clustering induced by incubation of T
cells with MHC–peptide oligomers leads to the induction of T-cell activation processes, including downregulation of engaged
receptors and upregulation of the cell-surface proteins CD69 and CD25. Dose–response curves for these T-cell activation
markers are bell-shaped, with different maxima and midpoints, depending on the valency of the soluble oligomer used. In this
study, we have analyzed the activation behavior using a mathematical model that describes the binding of multivalent ligands
to cell-surface receptors. We show that a simple equilibrium binding model accurately describes the activation data for CD4
T cells treated with MHC–peptide oligomers of varying valency. The model can be used to predict activation and binding
behavior for T cells and MHC oligomers with different properties.
INTRODUCTION
In recognition of and response to foreign antigens, CD4 T
cells have an important role in the immune system. CD4
T-cell activation is triggered upon specific interaction of
T-cell surface receptors (TCR) with foreign antigens bound
to class II major histocompatibility complex (MHC) pro-
teins found on the surface of B cells, macrophages, and
other antigen-presenting cells (Germain, 1994; Davis et al.,
1998). MHC-TCR engagement triggers a cascade of signal-
ing events, including phosphorylation of receptor subunits,
docking of receptor-associated signaling and adapter pro-
teins, activation of cytoplasmic signaling cascades, and
up-regulation of several gene products (Cantrell, 1996; Qian
and Weiss, 1997). The complete activation program also
requires participation of antigen-independent adhesion and
costimulatory molecules from both the T cell and antigen-
presenting cell (Chambers, 2001), which can lead to forma-
tion of cell-surface supramolecular activating clusters or
“immune synapses” (van der Merwe et al., 2000), and
eventually cytokine secretion, clonal proliferation, and in-
duction of other T-cell effector functions required to help
clear the foreign antigen from the host.
The precise molecular events that induce T-cell triggering
upon TCR ligation are not well understood, but substantial
evidence points to receptor clustering as an important com-
ponent of the signaling in this system (Germain, 1997).
Early studies showed that antibody-mediated clustering of
TCR (Janeway, 1995), or clustering of chimeric TCR cyto-
plasmic domains (Irving and Weiss, 1991; Letourneur and
Klausner, 1991) could trigger T-cell activation processes.
More recently, soluble MHC–peptide oligomers have been
used as reagents to investigate T-cell activation processes
(reviewed in Cochran et al., 2001a). These reagents include
antibody-linked MHC dimers (Abastado et al., 1995),
dimers created through chimeric fusions of MHC-peptide
complexes to antibody Fc domains (Casares et al., 1999;
Appel et al., 2000; Hamad et al., 1998), streptavidin-linked
oligomers of biotinylated MHC-peptide complexes (Boni-
face et al., 1998; Crawford et al., 1998), and a series of
chemically-defined MHC dimers, trimers, and tetramers
prepared using flexible peptide-based cross-linkers (Coch-
ran and Stern, 2000). These studies demonstrated that mul-
tivalent TCR engagement is necessary for CD4 T-cell
triggering, with an MHC dimer as the minimal activating
unit (Cochran et al., 2000; Boniface et al., 1998). T-cell
activation induced by such soluble oligomeric reagents ex-
hibits nonsaturating, bell-shaped dose–response curves
(Cochran et al., 2000), but these activation relationships
have not been related to binding constants or other molec-
ular properties of the system. Moreover, fluorescent MHC
oligomers increasingly are used to track antigen-specific
T-cell populations in clinical samples (Ferlin et al., 2000;
McMichael and O’Callaghan, 1998), and understanding the
correlation between binding levels and molecular properties
such as MHC–TCR affinity or TCR clustering is urgently
needed.
To gain insight into the binding behavior of MHC oli-
gomers, and the relationship between MHC–TCR binding
and the resultant activation response, we have applied a
simple receptor cross-linking model developed originally
for characterization of equilibrium binding of multivalent
ligands to receptors on mast cells (Perelson, 1981). Here, we
show that the model accurately describes the behavior of
soluble MHC oligomers in inducing activation processes in
T cells for a variety of oligomer valencies, MHC–TCR
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affinities, and cross-linking strategies. The striking correla-
tion of the model with the experimental data in this system
shows that several T-cell responses are directly related to
the number of multivalently engaged receptors. The behav-
ior of the model under different experimental conditions
suggests possible mechanisms for the cellular regulation of
antigen sensitivity in T cells.
MATERIALS AND METHODS
Preparation of class II MHC–peptide oligomers
HLA-DR1  and  extracellular domains (Cochran and Stern, 2000) were
expressed in Escherichia coli cells as inclusion bodies, solubilized in 8 M
urea, purified by ion exchange, and refolded by dilution of the denaturant
under redox-controlled conditions in the presence of peptide, as previously
described (Frayser et al., 1999). Cysteine residues introduced into the  or
 subunit C-termini (cys, cys, Lcys, and Lcys) were used for cross-
linking. In some experiments, the cysteine was introduced immediately
after the membrane proximal immunoglobulin domain (cys, cys); in others,
the 5–10-residue connecting-peptide region was included before the cysteine
(Lcys, Lcys). Antigenic peptide Ha[306–318] (PKYVKQNTLKLAT) de-
rived from influenza hemagglutinin (Lamb et al., 1982), control peptide
A2[103–117] (VGSDWRFLRGYKQYA) (Chicz et al., 1992), and cross-
linkers X3X (fKSGSKG) and X14X (fKSGSGESGSEGSSEGKG)
(Cochran et al., 2001b) and related trivalent and tetravalent peptide-based
cross-linkers (Cochran and Stern, 2000), where f is fluoresceinyl--alanine
and K is N()aminocaproylbenzylmaleimide lysine, were synthesized us-
ing 9-fluorenylmethoxycarbonyl (FMOC) chemistry, purified by reverse-
phase high-performance liquid chromatography, and verified using mass
spectrometry. The refolded HLA-DR1–peptide complexes carrying a cys-
teine on either the  or  subunit were oligomerized by reaction of the
introduced thiols with maleimidyl groups on the peptide-based cross-
linkers. Cross-linker was added in small aliquots to freshly-reduced MHC
protein at room temperature over a period of five hours to a final molar
ratio of MHC:cross-linker of 2:1 for dimers, 3:1 for trimers, and 4:1 for
tetramers (Cochran and Stern, 2000). Purified MHC–peptide oligomers
were isolated using two Superdex 200 HR 10/30 columns (Pharmacia,
Peapack, NJ) in series, and further characterized by SDS-PAGE (Cochran
and Stern, 2000). For binding assays, fluorescent MHC–peptide monomers
were prepared by reaction of the HLA-DR1-introduced cysteine residue
with fluorescein-malemide (Pierce, Rockford, IL) followed by purification
by gel filtration chromatography (Cochran and Stern, 2000).
T-cell activation and binding assays
The T-cell clone HA1.7 (Lamb et al., 1982) used in many of the experi-
ments presented herein is specific for the Ha peptide bound to HLA-DR1,
and was maintained by biweekly stimulation with peptide-pulsed irradiated
antigen-presenting cells and rested seven days before activation assays
(Cochran et al., 2000). Two HLA-DR1-restricted, Ha-peptide specific,
T-cell clones, Cl-1 (Sette et al., 1994) and HaCOH8 (gift of Corrine
Moulon, Warner-Lambert, Paris), and a short-term polyclonal T-cell line,
HA03 (Cameron et al., 2001), were maintained similarly. T-cell activation
assays were performed as previously described (Cochran et al., 2000).
Briefly, MHC–peptide oligomers were added to 7.5  104 T cells in
round-bottom 96-well plates and incubated at 37°C, 7% CO2. After the
desired incubation time, cells were placed on ice and stained concurrently
with fluorescent monoclonal antibodies against T cell surface markers:
R-phycoerythrin (PE)-labeled anti-CD3 (UCHT-1) and allophycocyanin
(APC)-labeled anti-CD69 (FN50) or APC-anti-CD25 (M-A251) (all from
Pharmingen, San Diego, CA). Cells were washed with phosphate-buffered
saline (1 mM KH2PO4, 10 mM Na2HPO4, 137 mM NaCl, 3 mM KCl, pH
7.4) containing 1% fetal bovine serum and 0.1% sodium azide and ana-
lyzed by flow cytometry. Fluorescence data were obtained with a Becton-
Dickinson FACS Calibur flow cytometer and analyzed using Cell Quest
software. The number of MHC–peptide complexes bound during the
course of the T-cell activation assay was measured simultaneously with
T-cell activation markers using the fluorescein molecules incorporated into
the cross-linkers and multicolor flow cytometry (Cochran et al., 2000). The
number of CD3 molecules downregulated upon oligomer treatment, and
the number of MHC–peptide complexes bound per cell, were converted
from mean fluorescence using SPHERO Rainbow calibration particles
(Spherotech, Libertyville, IL) containing known amounts of PE and fluo-
rescein equivalents.
Generation of calculated cross-linking and
binding curves
For a given KX, KD, and Rtot, the implicit equation for Req (see Eqs. 1 and
2 below) was solved numerically for each valency of oligomer and each
concentration using the secant method (Kreyszig, 1993). That value was
then used to calculate the number of oligomers bound per cell with each
possible valency. The calculations were performed using programs created
in FORTRAN 77 and MAPLE V. xlink, Rmulti, Rdimer, and Lbound were
calculated from binding distributions as described in the Model section of
this paper.
Fitting experimental activation and binding data
Fits of the model to the experimental sets were solved by a three-parameter
minimization of KX, KD, and scale factor, using known Rtot. Minimization
reduced the total 2 by iterative testing of combinations of parameter
values one interval above and below the current values of KD, KX, and scale
factor, and adopting the combination with the lowest 2 as the new values.
The interval was reduced until convergence. A wide range of initial guesses
was tried for each data set to ensure uniqueness of the fit parameters. The
uncertainty for each parameter, aj2 , was determined by
aj
2 
2
N np	
2  2p2 
 p		2 
,
where N is the number of measurements used for the fit, n is the number
of parameters being fit by the program, and the 2 values correspond to the
values calculated with the parameter p varying about the best fit value by
the interval 	 (Bevington, 1969).
MODEL
Distribution of bound states for a multivalent
ligand of a cell-surface receptor
A simple equilibrium model that describes the interaction of multivalent
ligands with cell-surface receptors was used to simulate activation dose–
response curves. Binding and cross-linking parameters were obtained by
least-squares fitting of curves to experimental binding and activation data.
This model was originally developed to describe general receptor binding
by multivalent ligands, and has been applied to the release of histamine
from basophils (Perelson, 1981), a response that requires receptor cross-
linking (DeLisi and Siraganian, 1979). Similar models have been used to fit
data for IgE-Fc receptor clustering (Hlavacek et al., 1999), dissociation of
insulin and nerve growth factor from their cross-linked receptors (DeLisi
and Chabay, 1979), viral attachment to cell-surface receptors (Wickham et
al., 1990), and dimeric MHC–peptide complexes binding to CD8 T cells
(Fahmy et al., 2001).
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The model describes the distribution of different bound states of a
multivalent ligand interacting with a monovalent receptor (Fig. 1). For
example, a ligand dimer may be bound monovalently (21) or divalently
(22), assuming that both ligand units can bind simultaneously, or it may not
be bound at all (20, Fig. 1, top). Similar states can be described for a ligand
tetramer (Fig. 1, bottom). The model can be used to describe the relative
amounts of these states under different conditions. The monovalent binding
of a ligand to its receptor is characterized by the equilibrium dissociation
constant KD (units of molarity). The tendency for multivalent binding is
assigned to the cross-linking constant KX (units of (#/cell)	1), with the
assumption that binding of each additional monomer within the oligomer is
described by the same constant. The actual independent modeling param-
eter is , the unitless product of the receptor density (Rtot/A, units of
(area)	1, where A is the surface area of the cell) and a 2-dimensional
equilibrium-binding constant (KX  A, units of area). Because the receptor
density is less convenient to measure experimentally than the number of
receptors per cell, we report the cross-linking constant KX 
 /Rtot. The
model also assumes that rapid binding equilibrium is attained, and that the
free ligand concentration is not significantly depleted by binding to cell
surface receptors. At the cell densities conventionally used in these exper-
iments (1–5  106 cells/mL), ligand is not significantly depleted for ligand
concentrations greater than 10	10 M, even at 100% receptor occupancy.
Calculation over a range of concentrations yields the distinctive distri-
bution of the various bound states, which is sensitive to changes in KD, KX,
and the total receptor number (Rtot). At equilibrium, the amount of oli-
gomer with valency (v) that is bound using i ligands can be found by
(Perelson, 1981)
i,eq 
v!
i! v i! KX
i	1
L0
KD
Req
i
, (1)
where i,eq is the number of oligomers of valency v bound i times per cell
at equilibrium, L0 is the bulk concentration of oligomer, and Req is the
number of unbound receptors per cell at equilibrium. The value of Req must
be found from the numerical solution of
Rtot  Req1 
 v L0KD 1 
 KXReqv	1 , (2)
and Rbound is found by
Rbound  Rtot  Req . (3)
Several related parameters describing the system can be extracted from
this type of calculation. For example, the number of cross-links (xlink)
formed by oligomers bound multivalently can be calculated as
xlink  
i
2
v
i 1vi,eq . (4)
This is the original measure that was used in previous studies (Perelson,
1981; Hlavacek et al., 1999). A tetramer bound divalently is considered to
have one cross-link, whereas one bound trivalently has two cross-links. In
addition, the number of cross-linked receptors (Rmulti), i.e., those associated
with oligomers bound multivalently, can be found by
Rmulti  
i
2
v
ivi,eq . (5)
The number of discrete receptor dimers per cell (Rdimer) can be found using
Rdimer  
i
2,4,6,...
v i
2 vi,eq . (6)
A tetramer bound tetravalently forms two discrete receptor dimers, whereas
one bound trivalently forms only one. Finally, the total number of oli-
gomers bound per cell (Lbound) can be calculated using
Lbound  
i
1
v
vi,eq. (7)
Theoretical distribution curves
The predicted distribution of bound states as a function of concentration for
fixed KX, KD, and Rtot values is shown for a dimeric ligand in Fig. 2, A, B,
and C, and for a tetrameric ligand in Fig. 2, D, E, and F. The plots in Fig.
2 were calculated using the same Rtot (24,000 per cell) and KD (1.4 M)
values, but with three different values for KX. When the cross-linking
tendency (KX) is low (2.0  10	5 per cell	1), as in Fig. 2, A and D, the
fraction of oligomers bound multivalently (using two, three, or four li-
gands) is low. The number of ligands bound monovalently rises rapidly to
saturation with increasing ligand concentration. In the tetramer plot (Fig.
2 D), the dashed line representing the sum of ligands bound multivalently
(Rmulti) is similar to the symmetric plot of divalently bound tetramers (42),
because few or no trivalently (43) or tetravalently (44) bound oligomers are
present. When the tendency to cross-link (KX) is ten-fold higher, as in Fig.
2, B and E, significant amounts of di-, tri-, and tetramerically bound ligands
accumulate at intermediate concentrations, and decrease at higher concen-
trations. The decrease at high concentrations can be understood by con-
sidering that mass action drives the formation of monovalently bound
oligomers at high concentrations of ligand. In the tetramer plot (Fig. 2 E,
solid line), the curve describing the total number ligands bound multi-
valently (Rmulti) begins to show some discernible asymmetry with a shal-
lower slope at low ligand concentration and a sharper slope at high
concentration. In Fig. 2, C and F, the cross-linking tendency (KX) is again
raised by 10-fold, and the asymmetry of the multivalently bound curve in
Fig. 2 F is even more pronounced. The curves representing oligomers
bound with their maximum valency rise rapidly with concentration. These
oligomers remain maximally bound with increasing concentration, and are
only slowly replaced by oligomers bound with lower valency, and then by
monovelently bound oligomers. The curve describing monovalently bound
oligomer rises at an even higher concentration than for lower KX, because
it is even more difficult for a monovalent interaction to compete with
multivalent interactions of bound oligomers.
The effect of varying parameters other than KX also can be determined.
If the KD is reduced by a factor of ten, the result is a linear shift of the
curves to lower concentrations. Increasing KD shifts the curves in the
opposite direction. Alternatively, if Rtot is changed ten-fold, an identical
FIGURE 1 Schematic description of oligomer binding for a dimer (top)
and a tetramer (bottom). The top row shows a dimer binding sequentially
to monomeric cell surface receptors. The terminology for the binding state
is shown above each oligomer. The bottom panels show the same scheme
for a tetramer binding sequentially to monomeric cell surface receptors.
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effect on the shape of the curves is observed as for the corresponding
change in KX; however, the height of the curve will be scaled to correspond
to the increased number of receptors per cell.
RESULTS
Analysis of experimental dose–response curves
for activation of a T cell clone by a series of
MHC oligomers
To investigate the molecular triggering mechanism of T-cell
activation, we have previously developed a series of chem-
ically-defined MHC–peptide oligomers of the human class
II protein HLA-DR1 (Cochran and Stern, 2000) and used
these to trigger activation processes in the well-character-
ized, influenza-specific human T-cell clone HA1.7 (Lamb et
al., 1982). This series of MHC dimers, trimers, and tetram-
ers was prepared using synthetic peptide-based cross-link-
ing reagents that were designed to be flexible and to allow
simultaneous binding of multiple MHC molecules to the
T-cell surface. Activation processes induced by these oli-
gomers were measured as changes in cell surface expression
of activation markers detected by multicolor flow cytom-
etry. The dose–response of T-cell activation induced by
MHC dimers, trimers, and tetramers was measured for three
activation markers: downregulation of T-cell receptor sub-
units (CD3) (Valitutti et al., 1997), upregulation of a T-cell-
associated lectin-like protein conventionally used as an
early T-cell activation marker (CD69) (Testi et al., 1994),
and upregulation of the interleukin-2 receptor  subunit
involved in the autocrine proliferative response (CD25)
(Waldmann, 1989). The dose–response for T-cell activation
triggered by each of the oligomers displayed a bell-shaped
curve (Cochran et al., 2000) similar to those predicted by
the simple equilibrium binding model. Increasing oligomer
size caused a shift in the activation maximum to lower
concentration and an increase in the maximum amplitude,
behavior characteristic of the model applied here (Perelson,
1981).
The dose–response curves were fit using the model de-
scribed above, using an experimentally determined value
(24,000) for Rtot, the number of receptors per untreated T
cell. Figure 3 shows the fits of the predicted Rmulti values to
experimental data for CD3 downregulation in the HA1.7 T
cell clone (Cochran et al., 2000) measured at 12 and 27 h,
respectively, after addition of MHC oligomers to the T cell
culture. Filled symbols indicate the experimental data (dia-
monds, dimers; triangles, trimers; squares, tetramers), and
smooth curves represent the predicted number of TCR mul-
tivalently bound (Rmulti) using best-fit values for KD, KX,
and a scale factor relating Rmulti to the experimental measure
FIGURE 2 Binding distribution plots. The distribution of variously bound oligomers as a function of oligomer concentration is shown in terms of the
number of MHC molecules bound. (A–C) The behavior of a dimeric ligand binding to monovalent cell surface receptors as the cross-linking capacity KX
increases in each panel as shown above the plots. (D–F) The behavior of a tetrameric ligand binding to monovalent cell surface receptors. Oligomers bound
monomerically (F), dimerically (), trimerically (Œ), and tetramerically (f), are shown. The solid line on the tetramer plots D–F represents the sum of
the multivalently bound oligomers, Rmulti.
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of internalized TCR. The curves obtained from a single
experiment with different oligomers were fit simulta-
neously. The predicted curves fit well to the experimental
data to within the expected uncertainty of the measure-
ments. Best-fit parameters for data collected at different
times after oligomer addition are similar: KD 
 1.4  0.1
M (12 hr) or KD 
 1.7  0.4 M (27 hr), and KX 

1.92  0.05  10	4 per cell	1 (12 hr) or KX 
 3.15 
0.01  10	4 per cell	1 (27 hr) (Table 1). The scale factor
relating the predicted number of multivalently-engaged re-
ceptors to the experimental number of downregulated re-
ceptors was 0.776  0.001 at 12 hr and 0.996  0.001 at 27
hr. The value of the scale factor approaches one at long
incubations, indicating that all engaged receptors eventually
become downregulated as part of the T-cell activation pro-
gram, as suggested by cellular studies (Valitutti et al., 1997;
Germain, 1997). The extracted values for KD are within the
range of affinities reported for other class II MHC-TCR
systems determined by direct binding measurements using
soluble receptors and ligands (Davis et al., 1998). The
extracted values for KX, and for the dimensionless value
 
 KX  Rtot, are comparable to those observed in other
systems (Hlavacek et al., 1999; Wickham et al., 1990;
Fahmy et al., 2001). For example, the KX determined for
IgE-Fc receptor cross-linking by multivalent antigen was
1.35  10	5 per cell	1 (Hlavacek et al., 1999), and for the
attachment of adenovirus to HeLa cells, a KX of 5  10	3
per cell	1 was calculated (Wickham et al., 1990). These
values correspond to  values of 13 and 30, respectively.
The  values determined for binding of class I MHC-IgG
fusion proteins to CD8 T cells range from 1 to 73 for cells
in different activation states (Fahmy et al., 2001). Our
values of  
 4–8 are within the range observed in these
systems.
Activation of HA1.7 T cells measured using other mark-
ers could also be described by the model. Upregulation of
the early activation marker CD69 also was described by the
model, although the data are noisier (Fig. 4 A). This fit
yielded a KD of 1.4  0.6 M, and a KX of 2.3  0.6 
10	4 per cell	1 (Table 1), values similar to those obtained
FIGURE 3 Comparison of experimental CD3 downregulation data and
model predictions. The predicted sum of multivalently bound oligomers at
each concentration was fit to experimental CD3 downregulation data for
treatment with a dimer (), trimer (Œ), and tetramer (f) (Cochran et al.,
2000). (A) The response of HA1.7 T cells at 12 h of incubation with the
oligomers. (B) The response at 27 h of incubation with the oligomers. Best
fit parameters shown in Table 1.
FIGURE 4 (A, B) CD69 and (C, D) CD25 upregulation data and model
predictions for a T cell clone. (A) The predicted sum of multivalently
bound oligomers at each concentration was fit to experimental HA1.7
CD69 upregulation data for treatment with a dimer (), trimer (Œ), and
tetramer (f) (Cochran et al., 2000). (B) The relationship between CD69
and CD3 responses with a best fit line. The linear relationship suggests that
a single scale factor could be used to relate CD69 response to Rmulti. (C)
The relationship between CD3 and CD25 responses with a best-fit qua-
dratic curve. The curved relationship suggests that CD25 response is not
directly related to Rmulti, and a quadratic filter was used to relate the model
predictions to the data. (D) The experimental HA1.7 CD25 response to the
dimer (), trimer (Œ), and tetramer (f) treatments fit using a quadratic
filter based on the relationship in (C). Parameters for the fits are shown in
Table 1.
TABLE 1 Binding and cross-linking parameters for several
experimental markers of T-cell activation for the clone HA1.7*
Experiment
KD
(M)
KX
(10	4 cell)
CD3 (12 hrs) 1.40 (0.12) 1.92 (0.05)
CD3 (27 hrs) 1.70 (0.40) 3.15 (0.01)
CD69 (12 hrs) 1.40 (0.60) 2.30 (0.60)
CD25 (27 hrs)† 1.80 (0.30) 3.00 (0.01)
Direct Binding 1.60 (0.30) 0.95 (0.01)
*Rtot was measured at 24,000 in these experiments, MHCs were linked
through  subunit cysteines (Lcys) using peptide-based cross-linkers
(Cochran et al., 2000). Values in parentheses represent parameter uncer-
tainties from the least squares fit (see Methods).
†CD25 upregulation was fit with this scale:
CD25 
 4  10	5  (Rmulti)2 	 0.0073  Rmulti.
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for CD3. If the CD3 downregulation and CD69 upregula-
tion data are correlated, a linear relationship is seen with a
slope of roughly 0.035 between the two (Fig. 4 B). This
corresponds well with the ratio of the fit scale factors
(0.027). Upregulation of CD25, the low-affinity IL-2 recep-
tor, was not described well by the model using a linear scale
factor (not shown). However, the plot of CD25 (IL-2R)
upregulation versus CD3 downregulation did not exhibit a
linear relationship as observed for CD69 with CD3, but
rather a distinct curve (Fig. 4 C). A best-fit quadratic func-
tion was found for the relationship of CD3 and CD25, and
that function was applied to the model predictions to better
represent the behavior of the data. After this application, the
CD25 upregulation data were fit well by the model (Fig.
4 D), giving best-fit values for KD (1.8  0.3 M) and KX
(3.00  0.01 per cell	1) (Table 1). Again, these values were
similar to those observed for the other markers.
Thus, a good correlation was observed between the pre-
dicted number of cross-linked receptors (Rmulti) and the
scaled experimental data (R2 
 0.99) as shown in Figs. 3
and 4. We also fit each of the data sets using the number of
cross-links (xlink), or the number of distinct dimers formed
(Rdimer), instead of the number of cross-linked receptors.
Although these fits were slightly less good (not shown), the
experimental data are not sufficiently precise to be able to
distinguish definitively between the different measures.
Analysis of other T-cell clones and MHC
cross-linking strategies
Additional tests of this model were performed using two
other influenza-specific T-cell clones, Cl-1 and HACoH8,
and also a short-term polyclonal influenza-specific T-cell
line raised from the peripheral blood of a DR1 homozy-
gous individual, HA03 (Fig. 5). The dose–response of CD3
downregulation for the MHC oligomer series was measured
for Cl-1 and HACoH8 after 24 hr (Fig. 5, A and B) and for
HA03 after 12 hr (Fig. 5 C). For Cl-1, the CD3 downregu-
lation dose–response curves were best-fit using KD 

5.00  0.01  10	5 M and KX 
 3.10  0.01  10	4 per
cell	1 (Table 2). These values are significantly different
from those observed for HA1.7, particularly for KD. The
other T-cell clone, HACoH8, exhibited KD 
 1.80 
0.07  10	6 M, and KX 
 42.2  1.4  10	4 per cell	1
(Table 2). In this case, the KX value is substantially different
from those observed for the other clones. Finally, the poly-
clonal line HA03 exhibited best-fit values of KD 
 1.60 
0.04  10	5 M and KX 
 0.96  0.04  10	4 per cell	1
(Table 2). These data show that KD and KX values can vary
among different T-cell lines, and that the model can de-
scribe these differences.
Another set of class II MHC oligomers has been used to
investigate the effect of receptor proximity and orientation
on T-cell activation (Cochran et al., 2001b). In this series,
MHC dimers were linked using a direct disulfide bond
between cysteines introduced at the end of the  or 
subunit, or using peptide-based synthetic cross-linkers of
varying length. Dimers linked through either the  or 
subunits, using either a disulfide bond (S–S) or a long
cross-linker (X14X), were tested for their ability to induce
CD3 downregulation in the HA1.7 T-cell clone (Fig. 6).
Dose–response curves for these dimers exhibited character-
FIGURE 5 CD3 response in other T cells. These plots show the CD3 downregulation response to dimer (), trimer (Œ), and tetramer (f) for the T cell
clones (A) Cl-1 and (B) HACoH8 and for the (C) polyclonal cell line HA03. The smooth curves show the model fits for these data sets. Model parameters
for these fits are shown in Table 2.
TABLE 2 Comparison of binding parameters among
different T cell clones*
T cell
Rtot
(per cell)
KD
(M)
KX
(10	4 cell)
HA1.7 24,000 1.70 (0.40) 3.15 (0.01)
Cl-1 16,700 60.00 (0.02) 3.10(0.01)
HACoH8 19,300 1.80 (0.07) 42.20 (1.4)
HA03† 27,000 16.00 (0.42) 0.96 (0.04)
*Parameters obtained by fitting CD3 downregulation data for HA1.7 (27
hrs), Cl-1 (24 hrs), HACoH8 (24 hrs), and HA03 (12 hrs). MHCs were
linked through  subunit cysteines using peptide-based cross-linkers
(Cochran et al., 2000). Rtot was measured directly by flow cytometry.
Values in parentheses represent parameter uncertainties from the least
squares fit (see Methods).
†Polyclonal T cell line.
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istic bell-shaped curves, with the S–S dimers (closed sym-
bols) activating more potently than the X14X dimers (open
symbols), with more activation induced at lower concentra-
tions and a higher maximum response. The activation data
were described well by the binding model (lines). Because
the cross-linking site is remote from the peptide-binding
region, the cross-links are not expected to interfere with the
TCR interaction, and a single KD value was globally fit to
the curves. The KX was allowed to vary between the curves.
The KD extracted from these curves (1.61  0.31 M) was
consistent with other KD values obtained for the HA1.7
T-cell clone. However, the best-fit KX varied significantly
within the series, with values (per cell)	1 of 18.6  0.8 
10	4 (S–S), 10.2  0.2  10	4 (S–S), 3.15  0.02 
10	4 (X14X), and 3.79  0.03  10	4 (X14X) (Table
3). The KX was greater for the S–S dimers, in which the
MHC monomer units are positioned close together, and
lower for the X14X dimers, which are more loosely tethered
by the long, flexible linker. Thus, the KX parameter appears
to reflect more facile receptor cross-linking for the more
compact dimers, as expected by their geometrical con-
straints.
Analysis of binding and competition data
In addition to the number of multivalently-bound receptors
Rmulti, the model can be used to predict the number of bound
ligands, Lbound. This parameter is a sum over all of the
variously bound states, and would be expected to corre-
spond to the experimental ligand binding behavior. Figure
7, A—C, shows the predicted binding behavior for a series
of oligomers of total valency 1 to 8, using values for KD (1.4
M) and KX (0.2–20  10	4 cell	1) similar to those ob-
served experimentally (and identical to those of Fig. 2). For
the lowest KX value (2  10	5 cell	1), the curves are
closely spaced and similarly shaped, with slightly more
shallow slope and closer spacing for the oligomers with
increased valency (Fig. 7 A). At saturating concentration,
distribution plots indicate that each oligomer is bound pre-
dominately monovalently (not shown). With a ten-fold in-
crease in KX, striking differences in shape are observed,
with a strong asymmetry and greater spacing at lower oli-
gomer concentrations as compared to the behavior at lower
KX (Fig. 7 B). At high concentration, the multivalent curves
cross below the curve for monomeric binding. A high-
valency oligomer will compete very effectively for binding
sites relative to a monomeric ligand, and will occupy a
given number of receptors using a smaller total number of
bound oligomers (Lbound) as compared to a monomer. With
another ten-fold increase in KX (Fig. 7 C), this behavior is
even more pronounced. Higher valency leads to a rapid rise
in the number of oligomers bound at lower concentration, as
seen by the wide spacing of the curves at low concentration.
At higher concentration, the strength of the multivalent
binding is a significant impediment to binding of additional
oligomers, and increasing oligomer size results in fewer
total oligomers bound as compared to smaller oligomers.
Thus, the predicted binding behavior is very sensitive to the
parameter KX. Changes in the parameter KD do not affect
the shape of the curves, but simply shift them to different
concentrations, with lower KD resulting in a linear shift to
lower concentrations (not shown). This is the same behavior
as observed for the binding distribution plots (Fig. 2). As
before, changes in Rtot resulted in changes identical to the
corresponding change in KX, but with changes in the satu-
ration value.
Experimental oligomer binding data were described well
by the model. Binding of the MHC oligomers can be mea-
sured concurrently with T-cell activation markers using
fluorescent labels incorporated into the oligomer cross-link-
ing reagents and multicolor flow cytometry (Cochran and
Stern, 2000), although internalization of bound oligomer
occurs during the extended incubations used for the activa-
tion assays (Cameron et al., 2001). The MHC oligomer
series used earlier in the activation experiments was tested
FIGURE 6 CD3 response to MHC dimers with different length cross-
links. This plot shows the CD3 downregulation in response to directly
disulfide-bonded S–S dimers linked through the cys () or the cys ()
cysteine, and X14X dimers connected by a long flexible linker between the
cys () or cys (ƒ) cysteine. The smooth lines show the model fit to the
data. Best-fit parameters are shown in Table 3.
TABLE 3 Comparison of KX parameters obtained with
differently linked MHC dimers*
MHC linkage†
Cross-linker
Length‡
(Å)
KX
( 10	4 cell)
S-S () 2 18.7 (0.8)
S-S () 2 10.2 (0.2)
X14X () 90 3.15 (0.02)
X14X () 90 3.78 (0.03)
*CD3 downregulation for HA1.7 at 20 hours. A single KD value was
globally fit to the data set as 1.6 M. Rtot was measured at 21,300 per cell.
†MHCs were linked by disulfide bonds (S–S) or long peptide-based cross-
linkers (X14X) through cystein residues on either the  or  subunit.
‡The length represents the predicted spacing of the linked C atoms when
the cross-linker is in an extended conformatioin.
Modeling T Cell Activation 2553
Biophysical Journal 81(5) 2547–2557
for direct binding to the HA1.7 clone (Fig. 8). The experi-
mental binding curves exhibit some of the characteristics of
the predicted binding curves, including variable spacing
depending on ligand concentration and convergence at high
concentration (Fig. 8). These data were fit to the modeled
total number of oligomers predicted to bind per cell at
equilibrium (Lbound). The best fit to this data (Fig. 8) gives
a KD of 1.6  0.3 M and a KX of 0.950  0.001  10	4
per cell	1 (Table 1). These values are similar to the KD and
KX values obtained independently from the T-cell activation
data (Table 1). The scale factor from the direct binding fit
was 0.806  0.002, which is somewhat below unity perhaps
because of partial quenching of the fluorescein labels in
acidic compartments after endocytosis (Cameron et al.,
2001).
The model can be used also to simulate competition
experiments, in which a constant concentration of labeled
“probe” oligomer is incubated in the presence of a vari-
able concentration of unlabeled “competitor” oligomer or
monomer. Figure 7, D–F, shows a series of predicted
competition curves for oligomers of various valency, in
each case using a constant concentration of probe tet-
ramer (35 nM). These conditions are similar to those that
have been used to evaluate relative oligomer binding
(Cochran et al., 2000; Reichstetter et al., 2000). As
before, three different values of KX in the range of the
experimental values are shown in Fig. 7, D–F, with each
panel varying by a factor of ten from the adjacent panel.
In contrast to the predicted binding curves, the shape of
the competition curves are quite similar for oligomers of
different valency, with only a small decrease in curve
spacing with increasing valency. Moreover, changes in
KX result only in small shifts on the concentration axis
rather than substantial changes in curve shape or spacing.
A similar effect can be seen for changes of KD. Thus,
although the predicted curves fit well to experimental
data (not shown), independent information about binding
and cross-linking parameters cannot be extracted from
this type of competition binding experiment.
FIGURE 7 Simulation of binding and competition. (A–C) Direct binding of multivalent ligands to a cell surface in terms of number of oligomers bound,
Lbound. Each curve shows the behavior of a given valency of oligomer binding to the cell. KX increases as shown from panels (A) to (C). (D–F) Competition
of a labeled tetramer (35 nM) by different valency unlabeled oligomers of the same ligand. KX increases as shown from (D) to (F). Rtot 
 24,000 per cell
in all panels
FIGURE 8 Direct binding data and fit. These curves show the experi-
mental results for direct binding of labeled monomer (F), dimer (),
trimer (Œ), and tetramer (f) (Cochran et al., 2000), and the model fit to
these data (lines). Parameters shown in Table 1.
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DISCUSSION
We have applied a simple two-parameter binding model to
the activation of antigen-specific T cells by oligomeric class
II MHC proteins. We find that the model accurately de-
scribes important features of the T-cell responses to soluble
MHC oligomers, including the bell-shaped, nonsaturating
concentration dependence and the variation of response
maxima with oligomer size. Similar dissociation constants
(KD) and cross-linking constants (KX) were extracted from
different assays, including direct oligomer binding data and
measurement of the T-cell activation markers CD3 down-
regulation, CD69 upregulation, and CD25 upregulation, in-
dicating that these parameters reflect intrinsic properties of
the system. The strong correlation observed throughout the
dose response between the levels of cellular activation and
the predicted number of multivalently bound receptors sug-
gests that these activation markers simply report the number
of suitably engaged receptors. Elaborate multi-step cyto-
plasmic signaling pathways have been elucidated for T cell
signaling pathways that lead to upregulation of gene expres-
sion, including receptor phosphorylation, assembly of
multi-component signaling complexes on receptor cytoplas-
mic domains, activation of various tyrosine and serine/
threonine kinase cascades, changes in intracellular Ca2
concentration, and activation and nuclear translocation of
transcription factors (Cantrell, 1996). The CD3 downregu-
lation (receptor internalization) pathway is less completely
understood, but appears to involve many of the same early
processes (Itoh and Germain, 1997). Despite the apparent
complexity of these signaling cascades, they do not appear
to substantially modify the original binding signal, and the
final cellular readout essentially reports the number of mul-
tivalently engaged receptors. For one marker (CD25), the
relationship between binding and response was best de-
scribed by a quadratic rather than linear relationship. Other
activation responses may show other dependences and may
incorporate information from other signaling pathways.
Nonetheless, the simple correspondence between the num-
ber of engaged receptors and the degree of cellular activa-
tion observed many hours after stimulation is striking.
Implicit in the model is the notion that multivalent en-
gagement of receptors leads to signaling, but that monova-
lent engagement does not. Although this is supported by
recent experimental work, particularly in CD4 T cells
(Boniface et al., 1998; Cochran et al., 2000), the biochem-
ical basis of signal initiation is not yet clear. Receptor
clustering is known to lead to phosphorylation of receptor
cytoplasmic domains, but, currently, it is not clear how
clustering results in kinase activation or in exposure of
cytoplasmic domains, although several models have been
proposed (Aivazian and Stern, 2000; Chan et al., 1994;
Shaw and Dustin, 1997). The modeling performed here
cannot definitively distinguish between a generic clustering
mechanism where Rmulti is the parameter that scales with
T-cell activation, or a specific dimerization mechanism
where Rdimer describes the triggering.
An individual’s T-cell repertoire includes many different
T-cell clones of varying MHC-TCR affinity and signaling
capacity (Janeway et al, 2001). Moreover, a T cell in dif-
ferent developmental and activation states has different sen-
sitivities to antigenic stimulation. Parameters derived from
least-squares fitting of the model to experimental activation
data can be used to understand and predict these functional
differences among T cells. We applied the model to several
different T-cell clones and to a polyclonal cell line repre-
sentative of a subpopulation present in blood. The KD and
KX parameters extracted from activation data differed for
the different T cells, with the differences consistent with
behavior observed in cellular assays. For example, the HA-
CoH8 clone has a KX value 13-fold higher than for HA1.7,
indicating an increased tendency to form receptor cross-
links. This clone can be stained by class II MHC oligomers
even at 4°C, whereas most clones, including HA1.7 and
Cl-1, require incubation at increased temperature to stain
with those reagents (Cameron et al., 2001). The temperature
dependence has been attributed to membrane or cytoskeletal
rearrangements that are necessary for monomeric TCR to
co-localize sufficiently to allow multivalent binding of
MHC oligomers, and which are inhibited at low temperature
(Cameron et al., 2001). The increased cross-linking ten-
dency of HACoH8 would increase its ability to multi-
valently engage MHC oligomers, allowing oligomer stain-
ing under conditions where other clones are not stained.
With the increasing use of MHC tetramers in detection
and analysis of specific T cells in clinical samples (Mc-
Michael and O’Callaghan, 1998), it is important to under-
stand the parameters that govern the multivalent MHC-TCR
interaction. Our analysis suggests that this relationship can
be complex, with substantial nonlinear contributions from
the receptor number (Rtot) and cross-linking propensity
(KX). In an early description of the use class II MHC
oligomers, a linear correlation was observed between oli-
gomer staining intensity and binding affinity KD, for several
T-cell hybridomas after correction for the total receptor
number (Crawford et al., 1998). Our analysis suggests that
this relationship will only hold for a restricted range of Rtot,
and only for cells with similar KX values. Finally, it is
important to note that IC50 values determined from compe-
tition analysis cannot be related to MHC-TCR KD values
unless the relevant KX values are known.
The sensitivity of the model to changes in KX suggests a
novel mechanism by which T cells could regulate their
activation state. A naı¨ve T cell, which has never previously
seen antigen, is much more difficult to activate than the
corresponding memory T cell, which is the long-lived prod-
uct of a prior encounter to antigen (Janeway et al., 2001).
Certain treatments with high antigen dose or with partial
antigenic stimuli are known to “anergize” T cells, i.e., to
drive them to nonantigen responsive state (Schwartz, 1997).
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In both cases, the responsive and nonresponsive T cells
express the same receptor, and so have the same MHC-TCR
affinity. It has generally been thought that these changes in
activation sensitivity are due to changes in the intracellular
signaling pathways. However, it is possible that T cells
could regulate their activity by changing their ability to
cluster TCR in the plane of the membrane, without any
change in cytoplasmic signaling processes. In our model,
this would correspond to a change in KX. Such changes
could be effected by alteration of receptor-cytoskeletal in-
teractions (Viola et al., 1999), by receptor localization to
membrane raft microdomains (Xavier and Seed, 1999), or
by alteration of the receptor oligomeric state (Fernandez-
Miguel et al., 1999). Recently, differences in the binding
avidity of naı¨ve as compared to activated T cells have been
observed, and attributed to differences in TCR oligomeric
state (Fahmy et al., 2001); these could as well be due to
differences in the dynamic cross-linking propensity rather
than the static oligomeric state. The pronounced effects on
ligand sensitivity that we have observed for relatively small
changes in KX (Figs. 2 and 5) suggest that substantial
changes in activation potential can be realized without any
change in the intracellular signaling pathways. In principle,
this possible mechanism is similar to one hypothesized to
regulate cellular sensitivity to soluble monomeric antigen
through changes in receptor organization (Bray et al., 1998).
There are some shortcomings of this approach in model-
ing the activation of T cells. We assume that all cross-
linking events are equivalent, but it is possible that sequen-
tial cross-linking interactions are governed by different KX
values. The model assumes a constant receptor number Rtot,
although activated receptors become downregulated as part
of the activation response (Liu et al., 2000), thus altering
Rtot during the course of the experiment. We used the initial
Rtot in calculating KX values, because the T-cell response to
soluble MHC oligomers is rapid (Boniface et al., 1998, and
J. R. Cochran and L. J. Stern, unpublished results). Using
the initial Rtot, similar KX values were obtained at different
times in the response with only a change in scale factor.
However, for derivation of an actual thermodynamic asso-
ciation constant, a more sophisticated analysis might be
warranted. Finally, because this is an equilibrium model, it
does not account for kinetic features of the interaction that
may play a role in triggering; for example, the off-rate of the
MHC-TCR complex has been proposed to be more impor-
tant in regulating activation behavior than the affinity (Mat-
sui et al., 1994).
Despite the simplifications made by the model, it cor-
rectly predicts T-cell binding and activation behavior within
observed experimental error. This model should prove use-
ful in guiding experimental detection of T cells using MHC
oligomers, and it provides a quantifiable measure of cellular
parameters that appear to regulate antigen sensitivity in T
cells.
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